支气管肺发育不良基因表达调控异常研究进展

林洁; 段山

doi:10.11852/zgetbjzz2021-0469

PDF(522 KB)

中国儿童保健杂志 ›› 2022, Vol. 30 ›› Issue (6) : 627-631. DOI: 10.11852/zgetbjzz2021-0469

综述

支气管肺发育不良基因表达调控异常研究进展

林洁, 段山

作者信息 +

Research progress on abnormal regulation of gene expression in bronchopulmonary dysplasia

LIN Jie, DUAN Shan

Author information +

文章历史 +

摘要

支气管肺发育不良(BPD)是早产儿最常见的慢性肺部疾病。BPD由多种因素引起,其本质是在遗传易感性的基础上,各种环境因素引起的肺损伤和发育中的未成熟肺修复之间的不平衡。研究显示BPD致病分子机理多涉及炎症细胞因子、非编码RNA和各种信号通路因子的异常表达调控。这些相关基因的异常表达,不仅影响了胚胎或早期胎儿肺的正常发育,并阻碍了新生肺损伤后肺的修复,或导致肺功能不全。单独或协同影响了BPD的发生发展。同时研究发现环境风险因素如高氧暴露、炎症导致基因表达异常也是BPD发生的原因之一,环境和基因共同作用推动了BPD的发生发展。

Abstract

Bronchopulmonary dysplasia (BPD) is one of the most common chronic lung diseases in primarily premature infants.BPD results from an imbalance between lung injury and repair caused by complex interactions between various environmental factors and genetic susceptibility in the developing lung.Studies have shown that BPD pathogenesis is mainly related to the abnormal expressions of inflammatory cytokines, non-coding RNA and signal pathway factors.The abnormal expression of pathogenesis-related genes not only affects the normal development of fetal or neonatal lung, but also impairs lung repair after early injury of the neonatal lung, and influences pulmonary insufficiency alone or cooperatively.Environmental risk factors, such as hyperoxia exposure and inflammation leading to abnormal gene expression, have also been found to be one of the causes of the development of BPD.The interaction between environmental factors and genetic susceptibility is an important mechanism for occurrence and development of BPD.

导出引用

林洁, 段山. 支气管肺发育不良基因表达调控异常研究进展[J]. 中国儿童保健杂志. 2022, 30(6): 627-631 https://doi.org/10.11852/zgetbjzz2021-0469

LIN Jie, DUAN Shan. Research progress on abnormal regulation of gene expression in bronchopulmonary dysplasia[J]. Chinese Journal of Child Health Care. 2022, 30(6): 627-631 https://doi.org/10.11852/zgetbjzz2021-0469

中图分类号： R722.6

参考文献

[1] Bancalari E, Jain D.Bronchopulmonary dysplasia: 50 years after the original description[J].Neonatology,2019,115(4):384-391.
[2] Stoll BJ, Hansen NI, Bell EF, et al.Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012[J].JAMA,2015,314(10):1039-1051.
[3] Parker RA, Lindstrom DP, Cotton RB.Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia[J].Semin Perinatol,1996,20(3):206-209.
[4] Leong M.Genetic approaches to bronchopulmonary dysplasia[J].Neoreviews,2019,20(5):e272-e279.
[5] Thebaud B, Goss KN, Laughon M, et al.Bronchopulmonary dysplasia[J].Nat Rev Dis Primers, 2019,5(1):78.
[6] Pan J, Zhan C, Yuan T, et al.Effects and molecular mechanisms of intrauterine infection/inflammation on lung development[J].Respir Res,2018,19(1):93.
[7] Keszler M, Sant'Anna G.Mechanical ventilation and bronchopulmonary dysplasia[J].Clin Perinatol,2015,42(4):781-796.
[8] Lapcharoensap W, Gage SC, Kan P, et al.Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort[J].JAMA Pediatr,2015,169(2):e143676.
[9] Abman SH, Bancalari E, Jobe A.The evolution of bronchopulmonary dysplasia after 50 years[J].Am J Respir Crit Care Med,2017,195(4):421-424.
[10] Morrow LA, Wagner BD, Ingram DA, et al.Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants[J].Am J Respir Crit Care Med, 2017,196(3):364-374.
[11] Kelly MS, Benjamin DK, Puopolo KM, et al.Postnatal cytomegalovirus infection and the risk for bronchopulmonary dysplasia[J].JAMA Pediatr,2015,169(12):e153785.
[12] Willis GR, Fernandez-Gonzalez A, Anastas J, et al.Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation[J].Am J Respir Crit Care Med,2018,197(1):104-116.
[13] Martinez FD.Early-life origins of chronic obstructive pulmonary disease[J].N Engl J Med, 2016,375(9):871-878.
[14] Wang J, Yin J, Wang X, et al.Changing expression profiles of mRNA, lncRNA, circRNA, and miRNA in lung tissue reveal the pathophysiological of bronchopulmonary dysplasia (BPD) in mouse model[J].J Cell Biochem,2019,120(6):9369-9380.
[15] Mao X, Guo Y, Qiu J, et al.Next-generation sequencing to investigate circular RNA profiles in the peripheral blood of preterm neonates with bronchopulmonary dysplasia[J].J Clin Lab Anal,2020:e23260.
[16] Lingappan K, Savani RC.The wnt signaling pathway and the development of bronchopulmonary dysplasia[J].Am J Respir Crit Care Med,2020,201(10):1174-1176.
[17] Warburton D, Bellusci S.Normal lung development needs self-eating[J].J Clin Invest, 2019,129(7):2658-2659.
[18] Yeganeh B, Lee J, Ermini L, et al.Autophagy is required for lung development and morphogenesis[J].J Clin Invest,2019,129(7):2904-2919.
[19] Durrani-Kolarik S, Pool CA, Gray A, et al.miR-29b supplementation decreases expression of matrix proteins and improves alveolarization in mice exposed to maternal inflammation and neonatal hyperoxia[J].Am J Physiol Lung Cell Mol Physiol,2017,313(2):339-349.
[20] Velten M, Britt RD, Heyob KM, et al.Prenatal inflammation exacerbates hyperoxia-induced functional and structural changes in adult mice[J].Am J Physiol Regul Integr Comp Physiol, 2012,303(3):279-290.
[21] Miyazono KI, Moriwaki S, Ito T, et al.Hydrophobic patches on SMAD2 and SMAD3 determine selective binding to cofactors[J].Sci Signal,2018,11(523).doi: 10.1126/scisignal.aao7227.
[22] Mathew R.Signaling pathways involved in the development of bronchopulmonary dysplasia and pulmonary hypertension[J].Children (Basel),2020,7(8).doi:10.3390/children7080100.
[23] Ruiz-Camp J, Quantius J, Lignelli E, et al.Targeting miR-34a/Pdgfra interactions partially corrects alveologenesis in experimental bronchopulmonary dysplasia[J].EMBO Mol Med, 2019,11(3):e9448.
[24] Syed M, Das P, Pawar A, et al.Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs[J].Nat Commun,2017,8(1):1173.
[25] Fulton CT, Cui TX, Goldsmith AM, et al.Gene expression signatures point to a male sex-specific lung mesenchymal cell pdgf receptor signaling defect in infants developing bronchopulmonary dysplasia[J].Sci Rep,2018,8(1):17070.
[26] Miller MF, Cohen ED, Baggs JE, et al.Wnt ligands signal in a cooperative manner to promote foregut organogenesis[J].Proc Natl Acad Sci U S A,2012,109(38):15348-15353.
[27] Hadchouel A, Franco-Montoya ML, Guerin S, et al.Overexpression of spock2 in mice leads to altered lung alveolar development and worsens lesions induced by hyperoxia[J].Am J Physiol Lung Cell Mol Physiol,2020,319(1):71-81.
[28] Ambalavanan N, Carlo WA.Bronchopulmonary dysplasia: new insights[J].Clin Perinatol,2004,31(3):613-628.
[29] Wang J, Dong W.Oxidative stress and bronchopulmonary dysplasia[J].Gene,2018,678:177-183.
[30] Wu Q, Chong L, Shao Y, et al.Lipoxin A4 reduces hyperoxia-induced lung injury in neonatal rats through PINK1 signaling pathway[J].Int Immunopharmacol,2019,73:414-423.
[31] Li Z, Choo-Wing R, Sun H, et al.A potential role of the JNK pathway in hyperoxia-induced cell death, myofibroblast transdifferentiation and TGF-beta1-mediated injury in the developing murine lung[J].BMC Cell Biol,2011,12:54.
[32] Alapati D, Rong M, Chen S, et al.Connective tissue growth factor antibody therapy attenuates hyperoxia-induced lung injury in neonatal rats[J].Am J Respir Cell Mol Biol,2011,45(6):1169-1177.
[33] Chen XQ, Wu SH, Luo YY, et al.Lipoxin A4 attenuates bronchopulmonary dysplasia via upregulation of let-7c and downregulation of TGF-beta1 signaling pathway[J].Inflammation, 2017,40(6):2094-2108.
[34] Alam MA, Betal SGN, Aghai ZH, et al.Hyperoxia causes miR199a-5p-mediated injury in the developing lung[J].Pediatr Res,2019,86(5):579-588.
[35] Yuan HS, Xiong DQ, Huang F, et al.MicroRNA-421 inhibition alleviates bronchopulmonary dysplasia in a mouse model via targeting Fgf10[J].J Cell Biochem,2019,120(10):16876-16887.
[36] Stouch AN, McCoy AM, Greer RM, et al.IL-1beta and inflammasome activity link inflammation to abnormal fetal airway development[J].J Immunol,2016,196(8):3411-3420.
[37] Liao J, Kapadia VS, Brown LS, et al.The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia[J].Nat Commun,2015,6:8977.
[38] Chao CM, Yahya F, Moiseenko A, et al.Fgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia[J].J Pathol,2017,241(1):91-103.
[39] Cho HY, van Houten B, Wang X, et al.Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice[J].Antioxid Redox Signal,2012,17(8):1066-1082.
[40] Collins JJP, Tibboel D, de Kleer IM, et al.The future of bronchopulmonary dysplasia: emerging pathophysiological concepts and potential new avenues of treatment[J].Front Med (Lausanne), 2017,4:61.
[41] Leroy S, Caumette E, Waddington C, et al.A time-based analysis of inflammation in infants at risk of bronchopulmonary dysplasia[J].J Pediatr,2018,192:60-65.
[42] Zemans RL, Briones N, Campbell M, et al.Neutrophil transmigration triggers repair of the lung epithelium via beta-catenin signaling[J].Proc Natl Acad Sci U S A,2011,108(38):15990-15995.
[43] Zacharias WJ, Frank DB, Zepp JA, et al.Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor[J].Nature,2018,555(7695):251-255.
[44] Sucre JMS, Deutsch GH, Jetter CS, et al.A shared pattern of beta-catenin activation in bronchopulmonary dysplasia and idiopathic pulmonary fibrosis[J].Am J Pathol, 2018,188(4):853-862.
[45] Yuan T, Volckaert T, Chanda D, et al.Fgf10 signaling in lung development, homeostasis, disease, and repair after injury[J].Front Genet,2018,9:418.
[46] Volckaert T, Yuan T, Yuan J, et al.Hippo signaling promotes lung epithelial lineage commitment by curbing Fgf10 and beta-catenin signaling[J].Development,2019,146(2).doi:10.1242/dev.166454
[47] Narasaraju T, Shukla D, More S, et al.Role of microRNA-150 and glycoprotein nonmetastatic melanoma protein B in angiogenesis during hyperoxia-induced neonatal lung injury[J].Am J Respir Cell Mol Biol,2015,52(2):253-261.
[48] Baker CD, Abman SH, Mourani PM.Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia[J].Pediatr Allergy Immunol Pulmonol,2014,27(1):8-16.
[49] Nakanishi H, Sugiura T, Streisand JB, et al.TGF-β-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung[J].American Journal of Physiology-Lung Cellular and Molecular Physiology,2007,293(1):151-161.